Liver Lineup: Updates & Unfiltered Insights

Liver Lineup: What's New in the ACG Hepatic Encephalopathy Guideline

ByNancy Reau, MD,Kimberly A. Brown, MD,Jasmohan Bajaj, MD

October 9th 2026

Jasmohan Bajaj, MD, joins Nancy Reau, MD, and Kim Brown, MD, to review what is new in the ACG hepatic encephalopathy guideline.

Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B

ByNancy Reau, MD,Kimberly A. Brown, MD,Tatyana Kushner, MD

July 9th 2026

Tatyana Kushner, MD, joins Kim Brown, MD, and Nancy Reau, MD, to unpack bepirovirsen's phase 3 data and its implications for HBV care.

Liver Lineup: HDV Diagnosis, Bulevirtide, and the Delta Pipeline

ByNancy Reau, MD,Kimberly A. Brown, MD,Tatyana Kushner, MD

June 18th 2026

Tatyana Kushner, MD, joins hosts Brown and Reau to discuss HDV testing gaps, bulevirtide approval, and the emerging delta hepatitis pipeline.

Liver Lineup: Closing the Gap in Women’s Liver Health

ByNancy Reau, MD,Kimberly A. Brown, MD,Meena Bansal, MD

April 16th 2026

Hosts are joined by Meena Bansal, MD, to discuss long-standing research gaps and what clinicians need to understand about sex-specific drivers of liver disease today.

Liver Lineup: Navigating Genetic Testing in Cholestatic Liver Disease

ByNancy Reau, MD,Kimberly A. Brown, MD,Saul Karpen, MD, PhD,Robert Gish, MD

April 7th 2026

Experts discuss when to use genetic testing in cholestatic disease, how to interpret results, and its growing role in diagnosis and management.

Liver Lineup: Breaking Down Barriers in Hepatitis B Management

ByNancy Reau, MD,Kimberly A. Brown, MD,Su Wang, MD, MPH

March 5th 2026

Hosts are joined by Su Wang, MD, MPH, to discuss the evolving management of hepatitis B and how to move care beyond silos with expanded treatment and provider empowerment.

Liver Lineup: Nutrition, Alcohol, and Liver Health in the New Dietary Guidelines

ByNancy Reau, MD,Kimberly A. Brown, MD,Jessica Mellinger, MD,Amanda Van Jacobs, MS, RDN, LDN, CCTD

February 4th 2026

Reau and Brown are joined by Amanda Van Jacobs, MS, RDN, and Jessica Mellinger, MD, to discuss the new dietary guidelines through the lens of liver health.

Liver Lineup: Managing MASLD and MASH Amid Limited Awareness, Overlapping Risk Factors

ByNancy Reau, MD,Kimberly A. Brown, MD

January 28th 2026

Reau and Brown discuss new data on MASH/MASLD, including awareness, referral patterns, discussions around alcohol, and emerging pharmacotherapies.

Liver Lineup: Advances, Gaps, and What’s Next in Viral Hepatitis

ByNancy Reau, MD,Kimberly A. Brown, MD

January 22nd 2026

Reau and Brown discuss recent research in hepatitis B, C, and D, including use of statins, GLP-1s, and more.

Liver Lineup: Bridging Innovation and Practice in Liver Transplant and HCC Care

ByNancy Reau, MD,Kimberly A. Brown, MD

January 16th 2026

Reau and Brown discuss emerging research in liver transplantation and hepatocellular carcinoma from AASLD The Liver Meeting 2025.

Liver Lineup: Advances in Portal Hypertension and Cirrhosis Management

ByNancy Reau, MD,Kimberly A. Brown, MD

January 5th 2026

Reau and Brown discuss new data on SGLT2 inhibitors, albumin dosing, AKI risk, and emerging at-home tools for hepatic encephalopathy in cirrhosis.

Liver Lineup: Breakthroughs in Cholestatic Liver Disease in 2025

ByNancy Reau, MD,Kimberly A. Brown, MD

January 1st 2026

This episode spotlights how advancements in 2025, including data from AASLD 2025, set the stage for future standards of care in cholestatic liver disease.

Liver Lineup: Navigating Hepatitis B Prevention After ACIP’s Birth Dose Shift

ByNancy Reau, MD,Kimberly A. Brown, MD

December 10th 2025

Reau and Brown discuss the recent CDC APIC decision to remove the universal birth-dose hepatitis B vaccine for infants born to mothers who test negative for HBV.

Liver Lineup: Unmet Needs and Evolving Standards in Alcohol-Associated Liver Disease, With Jessica Mellinger, MD

ByNancy Reau, MD,Kimberly A. Brown, MD,Jessica Mellinger, MD

October 14th 2025

Mellinger joins Liver Lineup to discuss current shortcomings in ALD diagnosis and care, the importance of addressing underlying alcohol use disorder, and more.

Liver Lineup: Innovations in Cholestatic Disease Management, With Kris Kowdley, MD

ByNancy Reau, MD,Kris Kowdley, MD, FACP, FACG, AGAF, FAASLD

September 18th 2025

Kowdley joins Liver Lineup to discuss evolving approaches in cholestatic liver disease and recent progress in PBC.

Liver Lineup: GLP-1 RAs and FGF21s for MASH, with Mary Rinella, MD

ByNancy Reau, MD,Kimberly A. Brown, MD,Mary (Maru) Rinella, MD

August 20th 2025

Hosts Nancy Reau and Kimberly Brown are joined by Mary Rinella to discuss the evolving MASH treatment landscape with GLP-1s and FGF21s in development.

Liver Lineup: Progress, Policy, and Barriers in Hepatitis C Elimination

ByKimberly A. Brown, MD,Nancy Reau, MD

July 14th 2025

Hosts Kimberly Brown and Nancy Reau discuss policy, clinical, and structural milestones enabling HCV elimination efforts and critical gaps impeding progress.

Liver Lineup: Advances in MASH, PSC, and PBC Care at EASL 2025

ByKimberly A. Brown, MD,Nancy Reau, MD

June 11th 2025

In the second part of a 2-part episode, hosts Kimberly Brown and Nancy Reau break down 3 more notable abstracts from the 2025 EASL Congress.

Liver Lineup: New MASLD and PBC Agents, PEth Testing, and HBV Functional Cure at EASL 2025

ByKimberly A. Brown, MD,Nancy Reau, MD

May 22nd 2025

Hosts Kimberly Brown and Nancy Reau break down 4 of the top abstracts presented at the 2025 European Association for the Study of the Liver (EASL) Congress.